THANK YOU FOR SUBSCRIBING
Having in-house dermatologists and its Research Center in Hamburg, bioskin is adept at handling new topical drug tests. Take an example of their unique psoriasis plaque test. It allows proof of the efficacy of a new compound in only a small number of patients. The test also integrates biophysical measurements giving an advantage of having proven efficacy before the pharma company progresses to more extensive trials. The inclusion of biophysical measurements to measure various skin properties like atrophy, the thickness of the skin and standardised imaging is exemplary of the expertise that bioskin has gained over 28 years of its existence. “Our research center participated in more than 150 clinical trials in the past 10 years,” adds Dr Wigger-Alberti.![]()
Our research center participated in more than 150 clinical trials in the past 10 years
Share this Article:
Tweet
|
Company
Bioskin GmbH
Headquarters
Hamburg, Germany
Management
Dr Walter Wigger-Alberti, CEO and Clinical Advisor Dermatology
Description
A full-service CRO offering global dermatologic consulting and all services for the management of Phase I-IV drug trials and claim support/safety studies